Boston Scientific (NYSE: BSX) will report its Q1 2018 earnings on April 25...we expect the company to post high single digit revenue growth, primarily led by continued high growth in the MedSurg segment. We also expect the company's Cardiovascular, and Rhythm Management to see single digit growth...
Boston Scientific (NYSE: BSX) will report its Q1 2018 earnings on April 25...we expect the company to post high single digit revenue growth, primarily led by continued high growth in the MedSurg segment. We also expect the company's Cardiovascular, and Rhythm Management to see single digit growth...
Share this Article
Recommended